1
|
Brevini TA and Gandolfi F: Parthenotes as
a source of embryonic stem cells. Cell Prolif. 41:20–30. 2008.
|
2
|
Kono T: Genomic imprinting is a barrier to
parthenogenesis in mammals. Cytogenet Genome Res. 113:31–35. 2006.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Shao H, Wei Z, Wang L, et al: Generation
and characterization of mouse parthenogenetic embryonic stem cells
containing genomes from non-growing and fully grown oocytes. Cell
Biol Int. 31:1336–1344. 2007. View Article : Google Scholar : PubMed/NCBI
|
4
|
Vrana KE, Hipp JD, Goss AM, et al:
Nonhuman primate parthenogenetic stem cells. Proc Natl Acad Sci
USA. 100:11911–11916. 2003. View Article : Google Scholar : PubMed/NCBI
|
5
|
Revazova ES, Turovets NA, Kochetkova OD,
et al: Patient-specific stem cell lines derived from human
parthenogenetic blastocysts. Cloning Stem Cells. 9:432–449. 2007.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Lin G, OuYang Q, Zhou X, et al: A highly
homozygous and parthenogenetic human embryonic stem cell line
derived from a one-pronuclear oocyte following in vitro
fertilization procedure. Cell Res. 17:999–1007. 2007. View Article : Google Scholar : PubMed/NCBI
|
7
|
Mai Q, Yu Y, Li T, et al: Derivation of
human embryonic stem cell lines from parthenogenetic blastocysts.
Cell Res. 17:1008–1019. 2007. View Article : Google Scholar : PubMed/NCBI
|
8
|
Allen ND, Barton SC, Hilton K, Norris ML
and Surani MA: A functional analysis of imprinting in
parthenogenetic embryonic stem cells. Development. 120:1473–1482.
1994.PubMed/NCBI
|
9
|
Sánchez-Pernaute R, Studer L, Ferrari D,
et al: Long-term survival of dopamine neurons derived from
parthenogenetic primate embryonic stem cells (cyno-1) after
transplantation. Stem Cells. 23:914–922. 2005.PubMed/NCBI
|
10
|
Lin H, Lei J, Wininger D, et al:
Multilineage potential of homozygous stem cells derived from
metaphase II oocytes. Stem Cells. 21:152–161. 2003. View Article : Google Scholar : PubMed/NCBI
|
11
|
Cibelli JB, Grant KA, Chapman KB, et al:
Parthenogenetic stem cells in nonhuman primates. Science.
295:8192002. View Article : Google Scholar : PubMed/NCBI
|
12
|
Kono T, Obata Y, Wu Q, et al: Birth of
parthenogenetic mice that can develop to adulthood. Nature.
428:860–864. 2004. View Article : Google Scholar : PubMed/NCBI
|
13
|
Morali OG, Jouneau A, McLaughlin KJ,
Thiery JP and Larue L: IGF-II promotes mesoderm formation. Dev
Biol. 227:133–145. 2000. View Article : Google Scholar : PubMed/NCBI
|
14
|
Hernandez L, Kozlov S, Piras G and Stewart
CL: Paternal and maternal genomes confer opposite effects on
proliferation, cell-cycle length, senescence, and tumor formation.
Proc Natl Acad Sci USA. 100:13344–13349. 2003. View Article : Google Scholar : PubMed/NCBI
|
15
|
Hikichi T, Wakayama S, Mizutani E, et al:
Differentiation potential of parthenogenetic embryonic stem cells
is improved by nuclear transfer. Stem Cells. 25:46–53. 2007.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Lin G, Xie Y, Ouyang Q, et al:
HLA-matching potential of an established human embryonic stem cell
bank in China. Cell Stem Cell. 5:461–465. 2009. View Article : Google Scholar : PubMed/NCBI
|
17
|
D’Amour KA, Agulnick AD, Eliazer S, Kelly
OG, Kroon E and Baetge EE: Efficient differentiation of human
embryonic stem cells to definitive endoderm. Nat Biotechnol.
23:1534–1541. 2005.
|
18
|
Kodama S, Toyonaga T, Kondo T, et al:
Enhanced expression of PDX-1 and Ngn3 by exendin-4 during beta cell
regeneration in STZ-treated mice. Biochem Biophys Res Commun.
327:1170–1178. 2005. View Article : Google Scholar : PubMed/NCBI
|
19
|
D’Amour KA, Bang AG, Eliazer S, et al:
Production of pancreatic hormone-expressing endocrine cells from
human embryonic stem cells. Nat Biotechnol. 24:1392–1401.
2006.PubMed/NCBI
|
20
|
Szabo P and Mann JR: Expression and
methylation of imprinted genes during in vitro differentiation of
mouse parthenogenetic and androgenetic embryonic stem cell lines.
Development. 120:1651–1660. 1994.PubMed/NCBI
|
21
|
Surani MA and Barton SC: Development of
gynogenetic eggs in the mouse: implications for parthenogenetic
embryos. Science. 222:1034–1036. 1983. View Article : Google Scholar : PubMed/NCBI
|
22
|
Surani MA, Barton SC and Norris ML:
Development of reconstituted mouse eggs suggests imprinting of the
genome during gametogenesis. Nature. 308:548–550. 1984. View Article : Google Scholar : PubMed/NCBI
|
23
|
Surani MA, Kothary R, Allen ND, et al:
Genome imprinting and development in the mouse. Dev Suppl. 89–98.
1990.
|
24
|
McGrath J and Solter D: Completion of
mouse embryogenesis requires both the maternal and paternal
genomes. Cell. 37:179–183. 1984. View Article : Google Scholar : PubMed/NCBI
|
25
|
Chen L and Li H: Progress in the studies
of parthenogenetic embryonic stem cells. Zhonghua Nan Ke Xue.
10:55–58. 2004.(In Chinese).
|
26
|
Maden M: Role and distribution of retinoic
acid during CNS development. Int Rev Cytol. 209:1–77. 2001.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Stafford D and Prince VE: Retinoic acid
signaling is required for a critical early step in zebrafish
pancreatic development. Curr Biol. 12:1215–1220. 2002. View Article : Google Scholar : PubMed/NCBI
|
28
|
Blumentrath J, Neye H and Verspohl EJ:
Effects of retinoids and thiazolidinediones on proliferation,
insulin release, insulin mRNA, GLUT 2 transporter protein and mRNA
of INS-1 cells. Cell Biochem Funct. 19:159–169. 2001. View Article : Google Scholar : PubMed/NCBI
|
29
|
Johannesson M, Stahlberg A, Ameri J, Sand
FW, Norrman K and Semb H: FGF4 and retinoic acid direct
differentiation of hESCs into PDX1-expressing foregut endoderm in a
time- and concentration-dependent manner. PLoS One. 4:e47942009.
View Article : Google Scholar
|
30
|
Petrik J, Pell JM, Arany E, et al:
Overexpression of insulin-like growth factor-II in transgenic mice
is associated with pancreatic islet cell hyperplasia.
Endocrinology. 140:2353–2363. 1999.PubMed/NCBI
|
31
|
Lopez MF, Dikkes P, Zurakowski D,
Villa-Komaroff L and Majzoub JA: Regulation of hepatic glycogen in
the insulin-like growth factor II-deficient mouse. Endocrinology.
140:1442–1448. 1999.PubMed/NCBI
|
32
|
Horii T, Kimura M, Morita S, Nagao Y and
Hatada I: Loss of genomic imprinting in mouse parthenogenetic
embryonic stem cells. Stem Cells. 26:79–88. 2008. View Article : Google Scholar : PubMed/NCBI
|
33
|
Vu TH and Hoffman A: Alterations in the
promoter-specific imprinting of the insulin-like growth factor-II
gene in Wilms’ tumor. J Biol Chem. 271:9014–9023. 1996.PubMed/NCBI
|
34
|
Christofori G, Naik P and Hanahan D:
Deregulation of both imprinted and expressed alleles of the
insulin-like growth factor 2 gene during beta-cell tumorigenesis.
Nat Genet. 10:196–201. 1995. View Article : Google Scholar : PubMed/NCBI
|
35
|
Sussenbach JS, Steenbergh PH and
Holthuizen P: Structure and expression of the human insulin-like
growth factor genes. Growth Regu. 2:1–9. 1992.PubMed/NCBI
|
36
|
De Sousa PA and Wilmut I: Human
parthenogenetic embryo stem cells: appreciating what you have when
you have it. Cell Stem Cell. 1:243–244. 2007.PubMed/NCBI
|